Cyberonics falls as Senate probes FDA turnaround
Thu May 19, 2005 10:07 AM ET
CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of the company's application to use an implantable device for epilepsy to also treat chronic depression.
[ ... Read the full report ... ]
07 April 2005
04 February 2005